Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Genentech
Roche
MS
multiple sclerosis
fenebrutinib
clinical trials
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Roche
Carmot Therapeutics
weight loss
obesity
M&A
3 standout digital innovations in pharma this year
Pharma Voice
Mon, 12/4/23 - 09:44 am
IDEA Pharma
innovation
digital pharma
AstraZeneca
Roche
Boehringer Ingelheim
Roche’s Genentech partners with Nvidia in AI drug deal
BioPharma Dive
Tue, 11/21/23 - 12:00 pm
Roche
Genentech
artificial intelligence
NVIDIA
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Roche
Genentech
Alzheimer's disease
gantenerumab
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Bayer
EMA
Eylea
Roche
Regeneron touts launch of high-dose Eylea in battle with Roche's Vabysmo
Fierce Pharma
Thu, 11/2/23 - 11:48 am
Regeneron
Eylea
Roche
Vabysmo
Roivant’s $7B Roche deal was a ‘moment of opportunity,’ CEO says
BioPharma Dive
Tue, 10/31/23 - 09:32 pm
Roivant
Televant
M&A
Roche
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Fri, 10/27/23 - 11:34 am
Vabysmo
Genentech
Roche
retinal vein occlusion
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
Reuters
Mon, 10/23/23 - 05:11 pm
Roche
legal
Biogen
biosimilars
Actemra
Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
ESMO
non-small cell lung cancer
Roche
Alecensa
AstraZeneca
Tagrisso
JNJ
Rybrevant
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific
Fierce Biotech
Thu, 10/19/23 - 11:36 am
Roche
diabetic retinopathy
solid tumors
bispecific antibodies
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Reuters
Thu, 10/19/23 - 10:03 am
Roche
earnings
Vabysmo
Roche pays $50M upfront to Monte Rosa in molecular glue deal
Fierce Biotech
Tue, 10/17/23 - 09:46 pm
Roche
molecular glue
Monte Rosa
QuEEN
protein degradation
Roche builds gene therapy portfolio with SpliceBio deal
Pharmaphorum
Tue, 10/17/23 - 11:00 am
Roche
Spark Therapeutics
SpliceBio
gene therapy
inherited retinal disease
Amid Eylea showdown, Roche's Vabysmo shows durability in retinal vein occlusion
Fierce Pharma
Wed, 10/11/23 - 10:13 am
Roche
retinal vein occlusion
Vabysmo
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Fierce Pharma
Wed, 10/11/23 - 10:07 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
BioSpace
Wed, 10/4/23 - 09:41 am
Roche
Genentech
clinical trials
Evrysdi
SMA
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »